Tricetin, a dietary flavonoid, inhibits proliferation of human breast adenocarcinoma MCF-7 cells by blocking cell cycle progression and inducing apoptosis

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 18, 2009, Pages 8688-8695

  Hsu, Y A Ling ^a   Uen, Yih Huei ^b   Chen, Yi ^b   Liang, Hsin Lin ^c,d   Kuo, P O Lin ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c Kaohsiung Municipal United Hospital   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis; ATM; Cell cycle; P53; Tricetin

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 9; CHROMONE DERIVATIVE; TRICETIN;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; NICK END LABELING; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANTICARCINOGENIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASE 9; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CHROMONES; G2 PHASE; HUMANS; IN SITU NICK-END LABELING;

ATAXIA TELANGIECTASIA; MURINAE;

EID: 70349335623     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf901053x     Document Type: Article

References (37)

1. (1) Ocaña, A.; Pandiella, A. Identifying Breast Cancer Druggable Oncogenic Alterations: Lessons Learned and Future Targeted Options. Clin. Cancer Res. 2008, 14, 961-970 (Pubitemid 351302540)
2. (2) Feuer, E. J.; Wun, L. M.; Boring, C. C.; Flanders, W. D.; Timmel, M. J.; Tong, T. The lifetime risk of developing breast cancer. J. Natl. Cancer Inst. 1993, 55, 892-897 (Pubitemid 23157129)
3. Doyle, D. M.; Miller, K. D. Development of new targeted therapies for breast cancer. Breast Cancer 2008, 15, 49-56.
4. Come, S. E.; Buzdar, A. U.; Ingle, J. N.; Johnston, S. R.; Brodie, A. M.; Coombes, R. C.; Miller, W. R.; Pritchard, K. I.; Winer, E. P.; Zujewski, J. A.; Goss, P. E. Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference. Cancer 2008, 112, 673-678
5. (5) Bruno, T.; De Nicola, F.; Iezzi, S.; Lecis, D.; D'Angelo, C.; Di Padova, M.; Corbi, N.; Dimiziani, L.; Zannini, L.; Jekimovs, C.; Scarsella, M.; Porrello, A.; Chersi, A.; Crescenzi, M.; Leonetti, C.; Khanna, K. K.; Soddu, S.; Floridi, A.; Passananti, C.; Delia, D.; Fanciulli, M. Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. Cancer Cell 2006, 10, 473-486. (Pubitemid 44854750)
6. (6) Roos, W. P.; Kaina, B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 2006, 12, 440-450 (Pubitemid 44291571)
7. (7) Lavin, M. F.; Kozlov, S. ATM activation and DNA damage response. Cell Cycle 2007, 6, 931-942 (Pubitemid 46658748)
8. (8) Hunt, C. R.; Pandita, R. K.; Laszlo, A.; Higashikubo, R.; Agarwal, M.; Kitamura, T.; Gupta, A.; Rief, N.; Horikoshi, N.; Baskaran, R.; Lee, J. H.; Löbrich, M.; Pauli, T. T.; Roti, J. L.; Pandita, T. K. Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status. Cancer Res. 2007, 67, 3010-3017 (Pubitemid 46724837)
9. Dornan, D.; Shimizu, H.; Mah, A.; Dudhela, T.; Eby, M.; O'rourke, K.; Seshagiri, S.; Dixit, V. M. ATM engages autodegradation of the E3 ubiquitin ligase COPl after DNA damage. Science 2006, 313, 1122-1126
10. (10) Stiff, T.; O'Driscoll, M.; Rief, N.; Iwabuchi, K.; Löbrich, M.; Jeggo, P. A. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 2004, 64, 2390-2396 (Pubitemid 38523891)
11. (11) Ryan, K. M.; Phillips, A. C.; Vousden, K. H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 2001, 13, 332-337 (Pubitemid 32429498)
12. Soussi, T. p53 alterations in human cancer: more questions than answers. Oncogene 2007, 26, 2145-2156
13. (13) Kulikov, R.; Winter, M.; Blattner, C. Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J. Biol. Chem. 2006, 281, 28575-28583 (Pubitemid 44507000)
14. (14) Pospíšilová, S.; Brázda, V.; Kucharíková, K.; Luciani, M. G.; Hupp, T. R.; Skládal, P.; Palecek, E.; Vojtesek, B. Activation of the DNAbinding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2. Biochem. J. 2004, 575, 939-947 (Pubitemid 38406871)
15. Yao, L.; Jiang, Y.; D'Arcy, B.; Singanusong, R.; Datta, N.; Caffin, N.; Raymont, K. Quantitative high-performance liquid chromatography analyses of flavonoids in Australian Eucalyptus honeys. J. Agric Food Chem. 2004, 52, 210-214
16. Campos, M. G.; Webby, R. F.; Markham, K. R. The unique occurrence of the flavone aglycone tricetin in Myrtaceae pollen. Z. Naturforsch. [C] 2002, 57, 944-946
17. Martos, I.; Ferreres, F.; Yao, L.; D'Arcy, B.; Caffin, N.; TomásBarberán, F. A. Flavonoids in monospecific eucalyptus honeys from Australia. J. Agric Food Chem. 2000, 48, 4744-4748
18. Martos, I.; Ferreres, F.; Tomás-Barberán, F. A. Identification of flavonoid markers for the botanical origin of Eucalyptus honey. J. Agrie Food Chem. 2000, 48, 1498-1502
19. Geraets, L.; Moonen, H. J.; Brauers, K.; Wouters, E. F.; Bast, A.; Hageman, G. J. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-l in pulmonary epithelial cells. J. Nutr. 2007, 137, 2190-2195
20. Wang, H. B.; Yao, H.; Bao, G. H.; Zhang, H. P.; Qin, G. W. Flavone glucosides with immunomodulatory activity from the leaves of Pleioblastus amarus. Phytochemistry 2004, 65, 969-974
21. Hsu, Y. L.; Cho, C. Y.; Kuo, P. L.; Huang, Y. T.; Lin, C. C. Plumbagin (5-hydroxy-2-methyl-l,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J. Pharmacol. Exp. Ther. 2006, 318, 484-494
22. (22) Baselga, J.; Mendelsohn, J. The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res. Treat. 1994, 29, 127-138 (Pubitemid 24104844)
23. Kühnau, J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet. 1976, 24, 117-191
24. Hollman, P. C.; de Vries, J. H.; van Leeuwen, S. D.; Mengelers, M. J.; Katan, M. B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995, 62, 1276-1282
25. (25) Hollman, P. C.; van Trijp, J. M.; Buysman, M. N.; van der Gaag, M. S.; Mengelers, M. J.; de Vries, J. H.; Katan, M. B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 1997, 418, 152-156 (Pubitemid 27514436)
26. Vousden, K. H.; Lane, D. P. p53 in health and disease. Nat. Rev. Mol Cell Biol. 2007, 8, 275-283.
27. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J. WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway. MoI Cancer Ther. 2005, 4, 1617-1627
28. Child, E. S.; Mann, D. J. The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability. Cell Cycle 2006, 5, 1313-1319
29. Gartel, A. L.; Radhakrishnan, S. K. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 2005, 65, 3980-3985
30. Matsuoka, S.; Ballif, B. A.; Smogorzewska, A.; McDonald, E. R. 3rd.; Hurov, K. E.; Luo, J.; Bakalarski, C. E.; Zhao, Z.; Solimini, N.; Lerenthal, Y.; Shiloh, Y.; Gygi, S. P.; Elledge, S. J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316, 1160-1166
31. (31) Brown, K. D.; Rathi, A.; Kamath, R.; Beardsley, D. I.; Zhan, Q.; Mannino, J. L.; Baskaran, R. The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet. 2003, 33, 80-84 (Pubitemid 36068687)
32. (32) Kuo, P. L.; Hsu, Y. L.; Cho, C. Y. Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. MoI Cancer Ther. 2006, 5, 3209-3221 (Pubitemid 46092064)
33. (33) Singh, S. V.; Herman-Antosiewicz, A.; Singh, A. V.; Lew, K. L.; Srivastava, S. K.; Kamath, R.; Brown, K. D.; Zhang, L.; Baskaran, R. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J. Biol. Chem. 2004, 279, 25813-25822 (Pubitemid 38756846)
34. Hideshima, T.; Mitsiades, C.; Akiyama, M.; Hayashi, T.; Chauhan, D.; Richardson, P.; Schlossman, R.; Podar, K.; Munshi, N. C.; Mitsiades, N.; Anderson, K. C. Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341. Blood 2003, 101, 1530-1534
35. Lee, Y. S.; Wan, J.; Kim, B. J.; Bae, M. A.; Song, B. J. Ubiquitindependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen. J. Pharmacol. Exp. Ther. 2006, 317, 202-208
36. (36) Kuo, P. L.; Chen, C. Y.; Hsu, Y. L. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells. Cancer Res. 2007, 67, 7406-7420 (Pubitemid 47206571)
37. (37) Schwarz, M.; Andrade-Navarro, M. A.; Gross, A. Mitochondrial carriers and pores: key regulators of the mitochondrial apoptotic program? Apoptosis 2007, 12, 869-876 (Pubitemid 46653296)